セッション詳細
- Chairs
- 渡辺 昌文（Yamagata University Faculty of Medicine Department of Cardiology, Pulmonology, and Nephrology）
- Chairs
- 山口 修（Ehime University Graduate School of Medicine Department of Cardiology, Pulmonology, Hypertension and Nephrology）
| O2-BC-1 | A Pacing-Controlled Protocol for Frequency-Diastolic Relations Distinguishes Diastolic Dysfunction Specific to A Mouse HFpEF Model |
|---|---|
| 沼田 玄理 （The University of Tokyo Hospital） |
| O2-BC-2 | Overexpression of vascular G protein-coupled receptor kinase 2 (GRK2) leads to uncontrolled hypertension and acute heart failure as in Clinical Scenario 1 |
|---|---|
| 矢野 裕己 （Department of Cardiovascular Medicine, Nara Medical University） |
| O2-BC-3 | Dantrolene improves diastolic property of left ventricle in mineralcorticoid-induced hypertensive rats |
|---|---|
| 縄田 純也 （Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine） |
| O2-BC-4 | RyR2-targeting therapy prevents ventricular tachycardia and left ventricular remodeling after myocardial infarction |
|---|---|
| 藤井 翔平 （Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine） |
| O2-BC-5 | Systemic administration of Empagliflozin Decreases Myocardial Interstitial Myoglobin Levels in Ischemia/Reperfusion Rats |
|---|---|
| 林田 智博 （Okayama University） |
| O2-BC-6 | Expression of Angiopoietin-like 4 (ANGPTL4) in Epicardial Adipose Tissue Is Increased in Patients with Coronary Artery Disease |
|---|---|
| 茂木 飛佑馬 （Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka） |
| O2-BC-7 | Mechanistic insight of SGLT2 inhibitors on epicardial adipose tissue |
|---|---|
| 髙野 正幸 （Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University） |
| O2-BC-8 | SGLT2 inhibitor Empagliflozin protects against heart failure through inhibition of inflammatory responses mediated by bone marrow-derived immune cells in mice. |
|---|---|
| 堀谷 啓太 （Department of Medicine II, Kansai Medical University） |
| O2-BC-9 | DNA damage predicts therapeutic prognosis in heart failure with reduced ejection fraction of various underlying diseases |
|---|---|
| 戴 哲皓 （Department of Cardiovascular Medicine, The University of Tokyo Graduate School of Medicine） |